MoneyWorks4Me

Gujarat Kidney And Super Speciality Ltd (GKSL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544666 NSE: GKSL Hospital & Healthcare Services | Small Cap | Guj. Kidney & Super Share Price

₹176.90 -6.25 (-3.41%)

As on 22-Sep'26 11:39

Gujarat Kidney And Super Speciality Ltd (GKSL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544666 NSE: GKSL Hospital & Healthcare Services | Small Cap | Guj. Kidney & Super Share Price

₹176.90 -6.25 (-3.41%)

As on 22-Sep'26 11:39

Key Metrics
Valuation Multiples
Market Cap
₹1,444 Cr.
Current Price
₹176.9
52-Week Low / High
₹98 / 187
TTM EPS
₹2
TTM Sales
₹101 Cr.
Book Value per Share
₹32.7
P/E Ratio
91.19
Lower than its 5-year historical median
Industry PE
101.7
Price to Book (P/B)
5.60
Price to Sales (P/S)
14.29
Lower than its 5-year historical median
EV/EBITDA
49.69
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
68.64%
Outperforms industry median
Return on Capital Employed (ROCE)
63.02%
Outperforms industry median
Return on Assets (ROA)
25.28%
Operating Profit Margin
41.1%
Net Profit Margin
23.61%
Gross Profit Margin
39.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
748.72%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
455.56%
Asset Quality
Promoter Holding
71.45%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹278 Cr.
Equity
₹15.8 Cr.
Face Value
₹2
All Time Low / High
₹98.25 / 185.90

Gujarat Kidney And Super Speciality stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Somewhat Undervalued

Price Trend

Strong
Q.1 Is Gujarat Kidney And Super Speciality Ltd a good quality company?
Gujarat Kidney And Super Speciality Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Gujarat Kidney And Super Speciality Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Gujarat Kidney And Super Speciality Ltd vs industry peers?
Gujarat Kidney And Super Speciality Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Gujarat Kidney And Super Speciality Ltd?
Promoters hold 71.45% of the Gujarat Kidney And Super Speciality Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Gujarat Kidney And Super Speciality Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gujarat Kidney And Super Speciality Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'22Mar'23Mar'24TTM
ROCE % 38.4%-1.7%30%-
Value Creation
Index
1.7-1.11.1-

Growth Parameters

Sales 0.80538
Sales YoY Gr.--100%NA-
Adj EPS 0-00.31
YoY Gr.--100%NA-
BVPS (₹) 0.10.10.531.5
Adj Net
Profit
0.1-018
Cash Flow from Ops. 00-2.1-
Debt/CF from Ops. 00-0.9-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPSNANANA372.7%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24TTM
Return on
Equity %
25.9-1.617.16.4
Op. Profit
Mgn %
91.3031.433.8
Net Profit
Mgn %
12.5019.321.2
Debt to
Equity
001.1-
Working Cap
Days
00255262
Cash Conv.
Cycle
00-268151

Valuation of Guj. Kidney & Super - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales00540
Operating Expenses + 00324
Manufacturing Costs0004
Material Costs0004
Employee Cost 0018
Other Costs 0018
Operating Profit -0-0217
Operating Profit Margin (%) --40.9%41.1%
Other Income + 1010
Exceptional Items 0000
Interest 0001
Depreciation 1003
Profit Before Tax 0-0213
Tax 0013
Profit After Tax 0-029
PAT Margin (%) --35.9%23.6%
Adjusted EPS (₹)0.00.00.51.7
Dividend Payout Ratio (%)0%0%0%0%
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 00226
Share Capital 00011
Reserves 00215
Debt +0023
Long Term Debt0022
Short Term Debt0001
Minority Interest0001
Trade Payables3323
Others Liabilities -0-01521
Total Liabilities 442055

Fixed Assets

Net Fixed Assets +301431
Gross Block301437
Accumulated Depreciation1006
CWIP 0000
Investments 0000
Inventories0001
Trade Receivables11415
Cash Equivalents 0013
Others Assets -0315
Total Assets 442055
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 00114
PBT 0-0213
Adjustment 10-04
Changes in Working Capital -10-1-0
Tax Paid -0-0-0-3
Cash Flow From Investing Activity + 000-18
Capex 000-18
Net Investments 00-0-0
Others 0000
Cash Flow From Financing Activity + 00-06
Net Proceeds from Shares 0005
Net Proceeds from Borrowing 00-01
Interest Paid 00-0-1
Dividend Paid 0000
Others 00-01
Net Cash Flow 0012
PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/A162.468.64
ROCE (%)N/AN/A35.6163.02
Asset Turnover Ratio000.391.07
PAT to CFO Conversion(x)N/AN/A0.51.56
Working Capital Days
Receivable Days00204.6087.80
Inventory Days0020.604.30
Payable Days003,365.80250.60

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gujarat Kidney And Super Speciality Ltd FAQs

The current trading price of Guj. Kidney & Super on 22-Sep-2026 11:39 is ₹176.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Sep-2026 the market cap of Guj. Kidney & Super stood at ₹1,444 Cr

The latest P/E ratio of Guj. Kidney & Super as of 21-Sep-2026 is 179.6.

The latest P/B ratio of Guj. Kidney & Super as of 21-Sep-2026 is 5.81.

The 52-week high of Guj. Kidney & Super is ₹186.8 and the 52-week low is ₹98.25.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Kidney & Super is ₹37.89 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gujarat Kidney And Super Speciality Ltd is a average quality company.

The key valuation ratios of Gujarat Kidney And Super Speciality Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Gujarat Kidney And Super Speciality Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Gujarat Kidney And Super Speciality Ltd

Gujarat Kidney and Super Speciality was incorporated under the name and style of ‘Vihaan Medicare Private Limited’, a private limited company on December 20, 2019. Subsequently, in order to align its name with the business carried out by the company of offering multi-speciality and super-speciality medical services, pursuant to a resolution passed by the board of directors in their meeting held on September 04, 2023, and by the shareholders in an extraordinary general meeting held on September 06, 2023, the name of the company was changed to ‘Gujarat Kidney and Super Speciality Private Limited’ on September 13, 2023. Further, the company was converted into a public limited company pursuant to a resolution passed by the board of directors in their meeting held on November 02, 2023 and by the Shareholders in an extraordinary general meeting held on November 04, 2023 and consequently the name of the company was changed to ‘Gujarat Kidney and Super Speciality Limited’.

The company operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are super speciality surgical services). Its hospitals provide integrated diagnostic services, either in-house, and pharmacies that cater to its patients. It endeavours to provide quality and affordable healthcare services to all its patients. The company wholly owns some of the hospitals but manage the operations of each of the hospitals through a separate professional management team. Each of its hospitals is managed by a Chief Operating Officer, who is responsible for supervising day to day functioning. This structure provides the company with greater control over its hospitals and helps it to deliver quality healthcare services.

The company is led by Pragnesh Yashwantsingh Bharpoda, who has vast experience in the medical industry. He has helped the company expand its geographical presence by strategically acquiring various multi-speciality hospitals, over the years.

Business area of the company 

The company, along with its subsidiaries, is a multi-specialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care. 

Services of the company

Specialities services

  • General Medicine
  • General Surgery
  • Laparoscopic Surgery
  • Metabolic and Obesity Surgery
  • IVF
  • Obstetric and Gynaecology (OBGY)
  • Ortho
  • Joint Replacement
  • Arthroscopy
  • Endocrinology
  • Diabetology
  • Pulmonology
  • Intensivist
  • Skin and VD
  • Radiology
  • Pathology
  • Psychiatrist
  • Paediatric
  • Ophthalmology
  • ENT
  • Physiotherapy
  • Dietician

Super Specialities services

  • Urology
  • Cardiology
  • Nephrology
  • Neurology
  • Neuro Surgery
  • Oncology
  • Onco Surgery
  • Renal Transplant
  • Vascular Surgery
  • Gastroenterology
  • Gastro Surgery
  • Plastic Surgery
  • Paediatric Surgery
  • Hematology
  • Spine Surgery

Awards, accreditations and recognition 

  • 2022: Registration of Gujarat Kidney Hospital with the Kidney Transplant Center under the Human Organs Transplantation Act, 1994.
  • 2023: Renewal of registration of Gujarat Kidney Hospital with Kidney Transplant Center under the Human Organs Transplantation Act, 1994.
  • 2023: Accreditation for its Gujarat Kidney Hospital by the National Accreditation Board for Hospital & Healthcare Provide.

History and milestones

  • 2014: Established and commenced operations of its first hospital under the name of ‘Gujarat Kidney Hospital’ at Vadodara, Gujarat.
  • 2018: Shifted Gujarat Kidney Hospital to a larger premises in Vadodara, Gujarat to expand the bed capacity from fifteen to sixty-five.
  • 2018: Established five sub-specialities in its uro department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at its Gujarat Kidney Hospital.
  • 2019: Set up an in-house interventional cardiology department under the name of ‘Gujarat Heart Care Unit’ for offering invasive cardiology services.
  • 2021: Successfully carried out its first laparoscopic radical prostatectomy at its Gujarat Kidney Hospital.
  • 2023: Established and commenced operations of its second hospital in Godhra, Gujarat.
  • 2023: Successfully carried out its first renal transplant at its Gujarat Kidney Hospital.
  • 2023: Successfully carried out its first Angiography at its Godhra Hospital.
  • 2023: Established three in-house super-speciality departments for cardiology, urology and nephrology at its Godhra Hospital.
  • 2024: Successfully carried out its first retrograde intrarenal surgery (RIRS) at its Godhra Hospital.
  • 2024: Acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it the company’s Subsidiary.
  • 2024: Acquired the Gujarat Kidney Hospital.
  • 2024: Acquired the Godhra Hospital.
  • 2024: Acquired controlling interest of 90% in M/s Surya Hospital and ICU.
  • 2024: Acquired controlling interest of 90% in M/s. Gujarat Surgical Hospital.
  • 2025: Acquired Ashwini Medical Centre.
  • 2025: Acquired Ashwini Medical Store.
  • 2025: Acquired 51% of equity shares of Harmony Medicare Private Limited.

You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now